Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance
暂无分享,去创建一个
John J. Heath | F. Boisvert | W. Miller | Alexandre Orthwein | C. Gonçalves | N. Braverman | K. Mann | E. Di Pietro | S. D. del Rincón | S. Prabhu | A. Bolt | M. Dahabieh | F. Huang | Raúl Ernesto Flores González | E. Khoury | Ziyao Xu | Joelle Rémy-Sarrazin | Michael S. Dahabieh | S. D. Del Rincon | S. D. Del Rincón | Christophe Gonçalves | Sonia V. del Rincón
[1] S. Subramani,et al. Balancing the Opposing Principles That Govern Peroxisome Homeostasis. , 2020, Trends in biochemical sciences.
[2] P. Strzyz. Foundations of ER-phagy regulation , 2020, Nature Reviews Molecular Cell Biology.
[3] C. Gonçalves,et al. Peroxisomes and cancer: The role of a metabolic specialist in a disease of aberrant metabolism. , 2018, Biochimica et biophysica acta. Reviews on cancer.
[4] Se-Jin Kim,et al. Catalase inhibition induces pexophagy through ROS accumulation. , 2018, Biochemical and biophysical research communications.
[5] Neng Zhu,et al. Lipid metabolism and carcinogenesis, cancer development. , 2018, American journal of cancer research.
[6] S. Tooze,et al. Autophagy pathway: Cellular and molecular mechanisms , 2018, Autophagy.
[7] Doo Sin Jo,et al. Pexophagy: Molecular Mechanisms and Implications for Health and Diseases , 2018, Molecules and cells.
[8] Wei Wang,et al. TRIM37, a novel E3 ligase for PEX5-mediated peroxisomal matrix protein import , 2017, The Journal of cell biology.
[9] W. Miller,et al. Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis , 2017, Cell Death and Differentiation.
[10] C. Genoud,et al. mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition , 2017, Oncotarget.
[11] Xiangjian Luo,et al. Emerging roles of lipid metabolism in cancer metastasis , 2017, Molecular Cancer.
[12] Joshua A. Bittker,et al. Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes , 2017, Cell.
[13] A. Moser,et al. The peroxisomal AAA ATPase complex prevents pexophagy and development of peroxisome biogenesis disorders , 2017, Autophagy.
[14] N. Braverman,et al. Peroxisome biogenesis disorders , 2016, Translational science of rare diseases.
[15] Max A. Horlbeck,et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.
[16] Navdeep S. Chandel,et al. Fundamentals of cancer metabolism , 2016, Science Advances.
[17] S. Subramani. A mammalian pexophagy target , 2015, Nature Cell Biology.
[18] T. Pandita,et al. ATM Functions at the Peroxisome to Induce Pexophagy in Response to ROS , 2015, Nature Cell Biology.
[19] I. Katona,et al. Regulation of endoplasmic reticulum turnover by selective autophagy , 2015, Nature.
[20] F. Boisvert,et al. Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage* , 2015, Molecular & Cellular Proteomics.
[21] W. Miller,et al. The role of eIF4E in response and acquired resistance to vemurafenib in melanoma. , 2015, The Journal of investigative dermatology.
[22] Jigang Wang,et al. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways , 2015, Autophagy.
[23] Seamus J. Martin,et al. Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.
[24] A. Moser,et al. Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy. , 2014, Cell metabolism.
[25] Marco Y. Hein,et al. Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.
[26] S. Gygi,et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy , 2014, Nature.
[27] A. Motley,et al. Deficiency of the exportomer components Pex1, Pex6, and Pex15 causes enhanced pexophagy in Saccharomyces cerevisiae , 2014, Autophagy.
[28] C. Semenkovich,et al. Peroxisomes: a nexus for lipid metabolism and cellular signaling. , 2014, Cell metabolism.
[29] Luke A. Gilbert,et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression , 2013, Nature Protocols.
[30] A. Martínez-Torteya,et al. SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.
[31] Melinda M. Mulvihill,et al. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity , 2013, Proceedings of the National Academy of Sciences.
[32] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[33] J. Lippincott-Schwartz,et al. NBR1 acts as an autophagy receptor for peroxisomes , 2013, Journal of Cell Science.
[34] W. Miller,et al. Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance , 2013, Cell Death and Disease.
[35] W. Sellers,et al. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance , 2013, Nature.
[36] A. Moser,et al. Functions of plasmalogen lipids in health and disease. , 2012, Biochimica et biophysica acta.
[37] S. Subramani,et al. Pexophagy: The Selective Degradation of Peroxisomes , 2012, International journal of cell biology.
[38] Qiongqing Wang,et al. Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation. , 2012, Cancer research.
[39] Lea M. Harder,et al. Supplemental material Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens , 2012 .
[40] M. Jäättelä,et al. Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy* , 2011, The Journal of Biological Chemistry.
[41] W. Miller,et al. Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells , 2011, PloS one.
[42] Jonathan Chernoff,et al. Faculty Opinions recommendation of COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. , 2011 .
[43] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[44] Damien Kee,et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. , 2010, Cancer cell.
[45] L. Hugendubler,et al. Transcriptional coactivator PGC-1α promotes peroxisomal remodeling and biogenesis , 2010, Proceedings of the National Academy of Sciences.
[46] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[47] Simon C Watkins,et al. Biochemical Isolation and Characterization of the Tubulovesicular LC3-positive Autophagosomal Compartment* , 2009, The Journal of Biological Chemistry.
[48] S. Ferdinandusse,et al. Bile acids: the role of peroxisomes , 2009, Journal of Lipid Research.
[49] K. Valerie,et al. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion , 2009, Molecular Cancer Therapeutics.
[50] Michele Pallaoro,et al. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics , 2007, Cell Research.
[51] Keiji Tanaka,et al. Excess Peroxisomes Are Degraded by Autophagic Machinery in Mammals* , 2006, Journal of Biological Chemistry.
[52] J. Cregg,et al. Pexophagy: The Selective Autophagy of Peroxisomes , 2005, Autophagy.
[53] J. Lemasters. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. , 2005, Rejuvenation research.
[54] S. Tamura,et al. The pathogenic peroxin Pex26p recruits the Pex1p–Pex6p AAA ATPase complexes to peroxisomes , 2003, Nature Cell Biology.
[55] Gerbert A. Jansen,et al. Peroxisomal fatty acid α- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases , 2001 .
[56] P. Vreken,et al. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. , 2001, Biochemical Society transactions.
[57] K. Ghaedi,et al. PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. , 2000, American journal of human genetics.
[58] H. Moser,et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.
[59] T. Deerinck,et al. Visualization of the Peroxisomal Compartment in Living Mammalian Cells: Dynamic Behavior and Association with Microtubules , 1997, The Journal of cell biology.
[60] I. Issemann,et al. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. , 1992, The EMBO journal.
[61] D. Johnson,et al. Very long-chain fatty acids in peroxisomal disease. , 1992, Advances in experimental medicine and biology.
[62] T. Tsukamoto,et al. Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes , 1990, The Journal of cell biology.
[63] R. Wanders,et al. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. , 1988, Journal of lipid research.